Article Versions Notes

Barbalata C-I, Porfire AS, Casian T, Muntean D, Rus I, Tertis M, Cristea C, Pop A, Cherfan J, Loghin F, et al. The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect. Pharmaceuticals. 2022; 15(10):1211. https://doi.org/10.3390/ph15101211

Barbalata, Cristina-Ioana, Alina Silvia Porfire, Tibor Casian, Dana Muntean, Iulia Rus, Mihaela Tertis, Cecilia Cristea, Anca Pop, Julien Cherfan, Felicia Loghin, and et al. 2022. "The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect" Pharmaceuticals 15, no. 10: 1211. https://doi.org/10.3390/ph15101211

Barbalata, C.-I., Porfire, A. S., Casian, T., Muntean, D., Rus, I., Tertis, M., Cristea, C., Pop, A., Cherfan, J., Loghin, F., & Tomuta, I. (2022). The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect. Pharmaceuticals, 15(10), 1211. https://doi.org/10.3390/ph15101211